Literature DB >> 23916779

Comparison of pre-hospital 600 mg or 900 mg vs. peri-interventional 300 mg clopidogrel in patients with ST-elevation myocardial infarction undergoing primary coronary angioplasty. The Load&Go randomized trial.

Kenneth Ducci1, Simone Grotti, Giovanni Falsini, Paolo Angioli, Francesco Liistro, Massimo Mandò, Italo Porto, Leonardo Bolognese.   

Abstract

Entities:  

Keywords:  Acute myocardial infarction; Clopidogrel loading dose; Clopidogrel pretreatment; Platelet reactivity

Mesh：

Substances：

Year:  2013        PMID： 23916779     DOI： 10.1016/j.ijcard.2013.07.012

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  6 in total

Review 1.  Benefits and risks of P2Y12 inhibitor preloading in patients with acute coronary syndrome and stable angina.

Authors:  Taylor C Bazemore; Michael G Nanna; Sunil V Rao
Journal:  J Thromb Thrombolysis       Date:  2017-10       Impact factor: 2.300

Review 2.  Contemporary Antiplatelet Pharmacotherapy in the Management of Acute Coronary Syndromes.

Authors:  Daniel R Mangels; Ashwin Nathan; Sony Tuteja; Jay Giri; Taisei Kobayashi
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-02-27

3.  Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Association of Interventional Cardiology (SICI-GISE) and Italian Society of Cardiac Surgery (SICCH): clinical approach to pharmacologic pre-treatment for patients undergoing myocardial revascularization procedures.

Authors:  Roberto Caporale; Giovanna Geraci; Michele Massimo Gulizia; Mauro Borzi; Furio Colivicchi; A Menozzi; Giuseppe Musumeci; Marino Scherillo; Antonietta Ledda; Giuseppe Tarantini; Piersilvio Gerometta; Giancarlo Casolo; Dario Formigli; Francesco Romeo; Roberto Di Bartolomeo
Journal:  Eur Heart J Suppl       Date:  2017-05-02       Impact factor: 1.803

Review 4.  Achieving the earliest possible reperfusion in patients with acute coronary syndrome: a current overview.

Authors:  Takahiro Nakashima; Yoshio Tahara
Journal:  J Intensive Care       Date:  2018-03-15

Review 5.  Pre-Hospital Antiplatelet Therapy for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: What We Know and What Lies Ahead.

Authors:  Enrico Fabris; Serge Korjian; Barry S Coller; Jurrien M Ten Berg; Christopher B Granger; C Michael Gibson; Arnoud W J van 't Hof
Journal:  Thromb Haemost       Date:  2021-04-30       Impact factor: 6.681

6.  Meta-analysis Comparing Outcomes of Type 2 Myocardial Infarction and Type 1 Myocardial Infarction With a Focus on Dual Antiplatelet Therapy.

Authors:  Christopher Reid; Ahmed Alturki; Andrew Yan; Derek So; Dennis Ko; Jean-Francois Tanguay; Amal Bessissow; Shamir Mehta; Shaun Goodman; Thao Huynh
Journal:  CJC Open       Date:  2020-02-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.